Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03382782 · ClinicalTrials.gov registry record · NA

Peer Navigators to Address Obesity-Related Concerns for African Americans With Serious Mental Illness

A NA study of Obesity and Mental Disorder, sponsored by Illinois Institute of Technology.

Completed
Registry status
NA
Development phase
234
Enrollment target
3
Study locations

NCT03382782 is a NA study of Obesity and Mental Disorder that has completed, run by Illinois Institute of Technology. The registered enrollment target is 234 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (71% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03382782, a NA study of Obesity and Mental Disorder, has completed, sponsored by Illinois Institute of Technology.

COMPLETED
Registry status
NA
Development phase
234 participants
Enrollment target
3
Study locations

Study Summary

People with serious mental illness such as schizophrenia and bipolar disorder experience high rates of physical illness and die earlier than people without serious mental illness (WHO, 2005). Health differences seem to be worse among African Americans (Weber, Cowan, Millikan \& Niebuhr, 2009). High rates of obesity among this group contribute to health and wellness concerns (de Hert et al., 2011), with African American women at higher risk of obesity than men. Behavioral weight loss interventions (BWLIs) may promote diet and physical activity that lead to weight loss, but healthy food and safe physical activity options are less available in low-income neighborhoods. Peer navigators have been found to be effective in addressing health differences, and may help people living in low-income communities find healthy food and activity resources (Fischer, Sauaia, \& Kutner, 2007). In addition, traumatic experiences are common among persons with serious mental illness as well as African Americans, and may impact weight. Through this project, investigators will test two interventions designed to address overweight and obesity among African Americans with serious mental illness. The first is a BWLI designed for persons with serious mental illness and adapted to meet the needs of African Americans. This program has 8-month intervention phase and 4-month maintenance phase. The intervention includes group weight management classes, group physical activity, individual visits to address barriers to meeting weight goals, and weigh-ins. The second intervention is a peer navigator program that assists people with serious mental illness in meeting their health needs in the community. Two-hundred and seventy (270) research participants will be recruited and randomly assigned to one of three conditions: BWLI program, BWLI program plus peer navigator, and treatment as usual (integrated physical and mental health care). Investigators will evaluate these interventions over a 12-month peri

Conditions Studied

Interventions

  • BEHAVIORAL BWLI
  • BEHAVIORAL BWLI & Peer Navigator
  • BEHAVIORAL Integrated Care

Study Locations (3)

Illinois

  • Illinois Institute of Technology - Chicago
  • Trilogy Behavioral Healthcare - Chicago
  • Access Community Health Network - Chicago

Trial Details

FieldValue
Enrollment Target 234 participants
Start Date 2017-12-12
Est. Completion 2021-03-11
Phase NA

Sponsor

Illinois Institute of Technology

8 total trials

What the Registry Record Tells You About NCT03382782

The ClinicalTrials.gov registry entry for NCT03382782 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 234 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (71% lower). The listed sponsor is Illinois Institute of Technology, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which BWLI is the first listed.

NCT03382782 reports 3 study locations spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT03382782 about?

NCT03382782 is a clinical study titled "Peer Navigators to Address Obesity-Related Concerns for African Americans With Serious Mental Illness". People with serious mental illness such as schizophrenia and bipolar disorder experience high rates of physical illness and die earlier than people without serious mental illness (WHO, 2005). Health differences seem to be worse among African Americans (Weber, Cowan, Millikan \& Niebuhr, 2009). High ...

What is the current status of trial NCT03382782?

This trial is currently completed. It is a NA study. The enrollment target is 234 participants. The study started on 2017-12-12. Estimated completion is 2021-03-11.

What conditions does trial NCT03382782 study?

This clinical trial studies the following conditions: Obesity, Mental Disorder.

What interventions are being tested in trial NCT03382782?

The interventions under investigation include: BWLI (BEHAVIORAL), BWLI & Peer Navigator (BEHAVIORAL), Integrated Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT03382782?

This trial is sponsored by Illinois Institute of Technology, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03382782 being conducted?

This trial has 3 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.